Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

HYTONE

HYDROCORTISONE

Standard Dose
2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HYTONE is listed in Drugs@FDA under application 080473 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCORTISONE Form and strength LOTION;TOPICAL - 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor VALEANT INTL Submission history Latest submission status date: 2002-03-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview HYTONE is listed in Drugs@FDA under application 080473 (ANDA). Marketing status: Discontinued Active ingredient HYDROCORTISONE Form and strength LOTION;TOPICAL - 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor VALEANT INTL Submission history Latest submission status date: 2002-03-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.